Peptides
| Cat No. | Product Name | Activity |
|---|---|---|
| HM-010 | PTD2 | WHSC1 inhibitor |
| PP-120 | (D)-PPA 1 | PD-1/PD-L1 interaction inhibitor |
| GJ-030 | 10Panx | Blocks pannexin-1 gap junctions |
| CG-010 | α-Calcitonin gene related peptide (human) |
Endogenous CGRP receptor agonist. |
| IG-010 | A20FMDV2 | Selective alpha-v beta-6 (αvβ6) integrin antagonist |
| CG-060 | AC 187 | Selective amylin antagonist |
| PP-100 | Ac2-26 | Annexin/lipocortin 1 mimetic |
| MC-020 | ACTH (1-39) (human) | Endogenous melanocortin receptor 2 (MC2R) agonist |
| MC-010 | alpha-MSH | Endogenous melanocortin receptor agonist |
| CG-040 | Amylin | Endogenous amylin receptor agonist |
| CG-050 | Amylin (8-37) (human) | Amylin receptor antagonist |
| NR-160 | Angiotensin (1-7) | Endogenous angiotensin peptide fragment |
| AT-010 | Angiotensin II | Endogenous vasoconstrictor hormone |
| CS-020 | Apelin 12 | C-terminal fragment of the 77 amino acid prepropeptide apelin |
| AR-010 | Apelin 36 (human) | Endogenous apelin agonist |
| CK-010 | ATI 2341 | CXCR4 allosteric agonist |
| IG-040 | ATN 161 | α5β1 integrin receptor antagonist |
| KS-190 | Autocamtide-2-related inhibitory peptide | CaM kinase II inhibitor |
| PR-020 | AY-NH2 | Selective PAR4 agonist |
| PP-060 | Bak BH3 | Bak BH3 sequence that binds to Bcl-xL |
| PN-100 | BAM (8-22) | Potent agonist of sensory neuron specific receptors |
| PN-110 | BAM 22P | Endogenous MRGPRX1 agonist |
| VP-020 | Bay 55-9837 | Selective VPAC2 agonist |
| PP-080 | Bid BH3 | Fragment of the BH3 domain of BID |
| GP-010 | BigLEN (mouse) | Endogenous GPR171 agonist |
| PP-070 | Bim BH3 | BH3 only protein Bim fragment |
| EI-010 | BM30 | N-terminal methyltransferase1/2 (NTMT1/2) inhibitor |
| EI-030 | BMP-2 derived peptide | Inhibits BMP-2 binding to BMP receptors type IA and type II |
| RK-010 | BMP2pp | BMP-2 mimetic |
| NR-150 | Bombesin | Endogenous mammalian neurotransmitter which activates bombesin receptors (BBR) 1, -2, and -3 |
| ER-010 | BQ 3020 | Selective ETB receptor agonist |
| PN-210 | Bradykinin | Endogenous bradykinin receptor agonist |
| PP-390 | BRC4wt | Blocks BRCA2–RAD51 interaction |
| PP-170 | Caveolin-1 scaffolding domain peptide | The binding domain of caveolin-1 |
| CG-030 | CGRP (8-37) (human) | CGRP antagonist |
| CG-020 | CGRP (8-37) (rat) | CGRP antagonist |
| CH-010 | Chemerin-9 | Chemokine-like receptor 1 (CMKLR1) agonist |
| PI-270 | Compstatin | C3 convertase inhibitor |
| SS-020 | Cortistatin 14 | Endogenous somatostatin like neuropeptide |
| CR-020 | CRF (human, rat) | Endogenous CRF receptor agonist |
| IM-010 | CXCL8 (54-72) | C-terminal CXCL8 peptide fragment corresponding to the core CXCL8 - glycosaminoglycan (GAG) binding region |
| IM-020 | CXCL8 (54-72) scrambled control | Scrambled version of CXCL8 (54-72) for use as a control |
| CK-040 | CXCL9(74–103) | Competes with CXCL8 for GAG binding |
| AM-180 | Cys-LL37 | The host defence peptide LL 37 with an additional N-terminal cysteine |
| EI-020 | DC432 | N-terminal methyltransferase1/2 (NTMT1/2) inhibitor, cell permeable |
| OP-010 | Decanoyl-RVKR-CMK | Proprotein convertase inhibitor |
| KA-010 | Dynorphin A | Endogenous kappa receptor agonist |
| IM-015 | E70K | Inhibits CXCL8-induced neutrophil transendothelial migration |
| EP-040 | EGFRvIII peptide | EGFRvIII derived epitope |
| MO-010 | Endomorphin-1 | Endogenous μ receptor agonist |
| MO-020 | Endomorphin-2 | Potent and selective μ opioid receptor agonist |
| CK-030 | EPI-X4 | Endogenous CXCR4 antagonist |
| GH-001 | Exendin-4 | Glucagon like peptide 1 (GLP-1) receptor agonist |
| GH-008 | Exendin-4 (3-39) amide | Glucagon like peptide 1 (GLP-1) receptor antagonist |
| GH-009 | Exendin-4 (5-39) amide | Glucagon like peptide 1 (GLP-1) receptor antagonist |
| GH-010 | Exendin-4 (9-39) amide | Glucagon like peptide-1 (GLP-1) receptor antagonist |
| AV-010 | F9170 | Inactivates HIV-1 virions |
| RT-030 | FGF7p | FGF7 mimetic |
| PP-110 | Foxy 5 | Wnt5a mimetic peptide |
| PR-080 | FSLLRY-NH2 | PAR2 antagonist |
| FZ-010 | Fz7-21 | Selective FZD7 antagonist |
| GA-030 | Galanin (1-29) (rat, mouse) | Galanin receptor agonist |
| GA-020 | Galanin (human) | Endogenous galanin receptor agonist |
| GJ-020 | Gap 26 | Gap junction channel blocker |
| GJ-010 | Gap 27 | Selective gap junction channel blocker |
| CC-010 | Gastrin I (human) | Endogenous CCK2 receptor agonist. |
| GH-190 | Ghrelin (human) | Endogenous agonist peptide for the ghrelin receptor |
| GH-180 | Ghrelin (rat) | Endogenous agonist peptide for the ghrelin receptor |
| GH-160 | GIP (1-39) | Endogenous truncated form of GIP |
| GH-150 | GIP (human) | Stimulates insulin release |
| GL-020 | GIP (porcine) | Stimulates insulin secretion |
| GH-170 | GIP-1 (3-42) (human) | Competes with GIP for the receptor binding site |
| GL-040 | GIP_HUMAN[22–51] | Endogenous proatherosclerotic peptide hormone |
| GH-030 | GLP-1 (1-36) amide | Proglucagon (72-107) proteolysis product |
| GH-020 | GLP-1 (1-37) (human, rat) | Pancreatic hormone from posttranslational proglucagon proteolysis |
| GH-050 | GLP-1 (7-36) amide (human, rat) | Insulinotropic incretin peptide hormone |
| GL-030 | GLP-1 (7-37) | Endogenous GLP-1 receptor agonist |
| GH-040 | GLP-1 (9-36) amide | Major metabolite of glucagon like peptide GLP-1 (7-36) amide |
| GL-010 | Glucagon (1-29) | Endogenous glucagon receptor agonist |
| GL-160 | GluR2 (831-842) | Peptide fragment derived from human GluR2 |
| CK-020 | HBP08 | CXCL12/HMGB1 heterocomplex inhibitor |
| FN-010 | Hexa-D-arginine | Furin inhibitor |
| PN-090 | Hoe 140 | Bradykinin B2 receptor antagonist |
| EP-030 | HOXB7 8-25 | Targets HOXB7 expressing tumours |
| IM-040 | IRBP (1-20) (human) | N-terminal fragment of the interphotoreceptor retinoid binding protein (IRBP) |
| IM-050 | IRBP (651-670) (human) | Residues 651 to 670 of human interphotoreceptor retinoid binding protein (IRBP) |
| ER-020 | IRL 1620 | Highly selective endothelin B receptor agonist |
| CR-010 | α-helical CRF (9-41) | CRF antagonist |
| DA-010 | KEMPFPKYPVEP peptide | Improves memory performance |
| NR-070 | Kisspeptin (zebrafish) | Zebrafish neuropeptide |
| NR-050 | Kisspeptin 10 (human) | Endogenous peptide for the kisspeptin receptor KISS1 (GPR54) |
| NR-060 | Kisspeptin 10 (rat, mouse) | Endogenous peptide for the rodent kisspeptin receptor KISS1 (GPR54) |
| KR-010 | Kisspeptin 234 | Kisspeptin receptor antagonist |
| PP-290 | KP1 | Disrupts TGF-β/TβR2 interaction |
| GT-010 | KRpep-2d | K-Ras inhibitor |
| PP-030 | KSL 128114 | Binds the PDZ1 domain of syntenin |
| RT-010 | KYL | EphA4 kinase inhibitor |
| AM-190 | LAP | Inhibits viral IRES mediated translation |
| PI-010 | Leupeptin hemisulfate | Reversible inhibitor of trypsin like and cysteine proteases, |
| PN-220 | LIH383 | Atypical chemokine receptor (ACKR3) agonist |
| AM-002 | LL 37 (human) scrambled | Scrambled control peptide for LL-37 |
| PI-020 | MDL 28170 | Calpain and cathepsin B inhibitor |
| MH-010 | Melanin concentrating hormone (human, mouse, rat) | Endogenous MCH agonist |
| PI-030 | MG 132 | Inhibits the chymotrypsin like activity of the 20S proteasome |
| KS-180 | MLCK inhibitor peptide 18 | Selective inhibitor of myosin light chain kinase |
| KS-210 | MOTS-c | AMPK activator |
| PI-290 | Multi-Leu peptide | PACE4 inhibitor |
| AM-185 | N-peptide | Binds the periplasmic chaperone protein chaperone SurA |
| TK-010 | Neurokinin B (human, porcine) | NK3 selective endogenous tachykinin agonist |
| BB-010 | Neuromedin B (porcine) | Mammalian bombesin like peptide |
| NU-010 | Neuromedin S (human) | Endogenous neuromedin U receptor agonist |
| NF-010 | Neuropeptide FF | Endogenous NPFF1 and NPFF2 agonist |
| GH-060 | Neuropeptide Y (human, rat) | Endogenous neuropeptide Y receptor agonist |
| GH-210 | Neuropeptide Y (porcine) | Endogenous neuropeptide Y agonist |
| NT-010 | Neurotensin | Endogenous neurotransmitter and endocrine modulator |
| PP-240 | NFAT Inhibitor | Calcineurin-NFAT interaction inhibitor |
| PN-010 | Nociceptin | Endogenous nociceptin receptor agonist |
| PP-300 | NP-12 | PD-1 - PD-L1 interaction blocker |
| GH-130 | Obestatin (rat) | Hormone which can suppress food intake |
| OX-050 | Orexin A (human, rat, mouse) | Endogenous OX1 and OX2 orexin receptor agonist |
| OX-020 | Orexin B (human) | Endogenous agonist at OX1 and OX2 receptors |
| OX-030 | Orexin B (mouse) | Endogenous OX1 and OX2 receptor agonist |
| EP-010 | OVA (257-264) | Antigenic ovalbumin peptide fraqment |
| OX-010 | OXA (17-33) | Orexin-1 receptor (OX1) agonist |
| GH-070 | Oxyntomodulin | Endogenous glucagon like peptide receptor agonist |
| AC-010 | p13 | GPR133 activator |
| AC-020 | p16 | GPR126 activator |
| PR-100 | P4pal10 | PAR4 antagonist |
| PA-030 | PACAP (6-38) | PAC1 receptor antagonist |
| PA-010 | PACAP 27 | Endogenous PAC1 receptor agonist |
| PA-020 | PACAP 38 | Endogenous PAC1 receptor agonist |
| MG-010 | PAMP 12 (human, porcine) | Endogenous MRGPRX2 agonist |
| MG-020 | PAMP 20 (human) | Endogenous MRGPRX2 agonist |
| NY-030 | Pancreatic polypeptide (human) | Endogenous agonist for the human NPY Y4 receptor |
| PH-030 | Parathyroid hormone (1 - 13) (human) | Amino acids 1-13 of the parathyroid hormone N-terminus |
| PH-010 | Parathyroid hormone (1-34) (human) | Parathyroid hormone receptor agonist |
| PH-040 | Parathyroid hormone (1-34) (rat) | Parathyroid hormone (PTH) receptor agonist |
| PP-380 | PD-L1Pep-2 | Binds to PD-L1 |
| PP-350 | PDHPS1 | YAP signaling pathway inhibitor |
| OP-020 | Pep2-8 | PCSK9 inhibitor |
| PI-120 | Pepstatin A | Aspartyl peptidase inhibitor |
| GH-120 | Peptide YY (3-36) (human) | Neuropeptide Y2 receptor agonist |
| GH-110 | Peptide YY (human) | Neuropeptide Y agonist that binds all subtypes with similar affinity |
| PN-020 | Peptide5 | Connexin43 hemichannel blocker |
| KS-060 | PKA inhibitor (6-22) amide | cAMP-dependent protein kinase (PKA) inhibitor |
| KS-050 | PKI (5-24) | cAMP-dependent protein kinase A (PKA) inhibitor |
| OR-010 | Prosaptide TX14(A) | GPR37 and GPR37L1 agonist |
| PP-050 | PUMA BH3 | BH3 domain fragment of PUMA |
| PI-280 | Q14 | USP30 inhibitor |
| PN-070 | R 715 | Bradykinin B1 receptor antagonist |
| KS-120 | R18 | 4.3.3 proteins antagonist |
| PP-310 | Rb4 | Induces expression of HMGB1 and calreticulin |
| GH-220 | RG33 | Apolipoprotein A1 (ApoA-I) mimetic, improves glucose clearance and control |
| IG-030 | RGDS peptide | Integrin receptor inhibitor |
| NA-010 | Rice-memolin | Rice derived peptide able to improve cognitive decline |
| PP-330 | RS17 | CD47 - SIRPα signalling inhibitor |
| IG-020 | RTDLDSLRTYTL | Alpha(v) beta(6) integrin (avb6) inhibitor |
| CY-030 | rytvela | IL-1 receptor allosteric antagonist |
| CY-040 | rytvela scrambled peptide | Scrambled control peptide for rytvela |
| CY-010 | S1H | Human growth hormone receptor antagonist |
| CY-020 | S7 | Interleukin-6 inhibitor |
| NR-180 | S9pep | SOX9 mimetic |
| NR-170 | Saralasin | Angiotensin II receptor partial agonist |
| AT-020 | Sarilesin | Angiotensin receptor antagonist |
| CV-050 | SBP1 | Binds to the SARS-CoV-2 receptor binding domain |
| PR-110 | SFFLRN-NH2 | Protease activated receptor-1 (PAR-1) activator |
| EP-020 | SFKEELDKYFKNHTSP | Epitope from the S2 protein of SARS-CoV-2 |
| OR-030 | SHBG141–161 | GPRC6A agonist |
| PR-060 | SLIGKV-NH2 | Protease activated receptor 2 (PAR2) agonist |
| PR-030 | SLIGRL-NH2 | PAR2 activating peptide |
| PP-360 | SMRwt | Disrupts the Nef-mortalin interaction, anti-metastatic |
| SS-010 | Somatostatin 14 | Endogenous somatostatin receptor agonist |
| TP-020 | SOR-C13 | TRPV6 antagonist |
| TL-010 | SPA4 peptide | TLR4 interacting peptide |
| KC-040 | Spadin | TREK-1 channel blocker |
| GA-010 | Spexin | Endogenous galanin receptor 2/3 agonist |
| NR-140 | Substance P | Endogenous neurokinin-1 receptor (NK1R) agonist |
| IG-050 | Synstatin | Syndecan-1 mediated integrin activation inhibitor |
| PR-050 | tcY-NH2 | Selective PAR4 antagonist |
| KC-020 | Tertiapin | Selective IKACh blocker |
| KC-030 | Tertiapin LQ | Selective Kir1.1 blocker |
| KC-010 | Tertiapin Q | Inward rectifier K+ channel blocker |
| PR-040 | TFLLR-NH2 | PAR1 selective agonist |
| TP-030 | TIP | TRPV1 inhibitor |
| PH-020 | TIP 39 | Endogenous parathyroid hormone 2 receptor agonist |
| RT-020 | TLQP 21 | VGF derived peptide |
| PP-280 | TPP-1 | Blocks PD-1/PD-L1 interaction |
| PR-010 | TRAP | Thrombin receptor agonist |
| PR-070 | TRAP 6 | PAR1 agonist |
| PR-090 | TRAP 6 amide | PAR1 agonist |
| NO-010 | UFP 101 | Potent and selective nociceptin receptor antagonist |
| PP-320 | VGN50 | Blocks MYC activation |
| VP-010 | VIP | Endogenous VPAC1 and VPAC2 agonist. |
| AV-020 | VIRIP | Endogenous HIV-1 inhibitor |
| IG-060 | VnP-16 | β1 and αvβ3 integrin signaling modulator |
| OR-020 | VPM-p15 | GPR64 (ADGRG2) agonist |
| PN-120 | WaTx | Stabilizes the transient receptor potential cation channel 1 (TRPA1) in an active state |
| FR-010 | WKYMVm | FPR1, FPR2 and FPR3 receptor agonist |
| FR-030 | WKYMVM | Selective FPRL1 and FPRL2 receptor agonist |
| FR-020 | WRW4 | Selective formyl peptide receptor 2 (FPR2) antagonist |
| CS-010 | Z-DEVD-FMK | Cell-permeable, irreversible caspase-3 inhibitor |
| PI-250 | Z-VAD-FMK | Pan-caspase inhibitor |
| KS-170 | ZIP | Protein kinase Mζ inhibitor |
| OX-040 | [Ala11,D-Leu15]-Orexin B | Potent and selective orexin2 receptor agonist |
| VR-010 | [Arg8]-Vasopressin | Vasopressin receptor agonist |
| NY-010 | [cPP1-7,NPY19-23,Ala31,Aib32,Gln34] - hPancreatic polypeptide | Potent and selective Y5 agonist |
| DR-010 | [D-Ala2]-Deltorphin II | Highly selective δ receptor agonist |
| GH-200 | [D-Lys3]-GHRP-6 | Ghrelin receptor (GHS-R1a) antagonist |
| GR-010 | [Des-octanoyl]-Ghrelin (human) | Non acylated form of ghrelin |
| NY-020 | [Leu31,Pro34]-Neuropeptide Y (human, rat) | Selective neuropeptide Y Y1 receptor agonist |
| DR-020 | [Leu5]-Enkephalin | Endogenous μ- and δ-opioid receptor agonist |
| AR-020 | [Pyr1]-Apelin 13 | Endogenous agonist for the apelin APJ receptor |
Contact Information
To place an order, or for customer services, order processing or technical support please contact us on:
UK, Europe and RoW
Tel: (+44) 01392 422205Fax: (+44) 01392 279510
info@iscabiochemicals.com
USA and Canada
Tel: 610-994-1134
Toll Free: 855-FOCUS21 (855-362-8721)
Fax: 610-465-9100
France
CliniSciences
Tel : +33 9 77 40 09 09
Fax : +33 9 77 40 10 11
Orders and customer support : info@clinisciences.com
Germany, Switzerland, Austria
BIOZOL Diagnostics
Tel: +49 (089) 3799 666-6
Fax: +49 (089) 3799 666-99
Orders, Technical and Customer support: info@biozol.de
Italy
Labospace
Tel: +39 02 35980841
Fax +39 02 359808004
Orders: info@labospace.com
Spain and Portugal
Abyntek Biopharma
Tel: +34 94 404 80 80
Fax: +34 94 404 80 81
Orders: info@abyntek.com
BIOHUB INTERNATIONAL
上海起发实验试剂有限公司
Tel: +86-15921799099
Tel: +86-021-50724187
Fax: +86-021-50724961
Orders: sale3@78bio.com
India
BTL Biotechno Labs Pvt Ltd
Tel: +91-8860924629
07291852429
Orders, Technical and Customer support: info@biotechnolabs.com
Japan
Namiki Shoji Co.
Tel：+81-050-5527-9850
Fax：+81-3-3352-2196
email: globalbusiness1@namiki-s.co.jp